Most notably, the mutation frequencies of TP53, ERBB2 and CDK12, TOP2A, SPOP, RARA, PIK3CA, PTK2, and FAT4 were significantly different among the four BC subtypes. This evidence concerns the gene CDK12 and breast cancer.